PUBLIC HEALTH
Global burden of aortic aneurysm from high body mass index and systolic blood pressure in older adults: 1990–2021 and projections to 2050
More details
Hide details
1
The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
2
Shantou University Medical College, Shantou, Guangdong, China
Submission date: 2026-01-31
Final revision date: 2026-03-15
Acceptance date: 2026-04-18
Online publication date: 2026-05-28
Corresponding author
Chengcheng Zhang
The First Affiliated Hospital of Shantou University Medical College, China
Arch Med Sci 2026;22(3):1292-1302
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Aortic aneurysm is a life-threatening vascular condition with a high case-fatality rate, yet the specific contributions of modifiable risk factors to its burden in the rapidly growing population of older adults remain poorly quantified. This study aimed to quantify the mortality and disability burden of aortic aneurysm attributable to high body mass index and high systolic blood pressure in adults aged 60 years and older from 1990 to 2021, and to project future trends to 2050.
Material and methods:
Using data from the Global Burden of Disease (GBD) 2021 study, we analysed deaths and disability-adjusted life-years (DALYs) across 204 countries and territories. We assessed socio-demographic inequality using the slope index of inequality and concentration index, decomposed changes into demographic and epidemiological drivers, and projected future trends using Bayesian age-period-cohort models. Trends are reported as average annual percentage changes with 95% uncertainty intervals (UIs) or confidence intervals (CIs).
Results:
In 2021, high body mass index (BMI) accounted for 9,476 deaths (95% UI: 4,908–16,032) and 164,396 DALYs (86,431–277,024) globally (age-standardised death rate (ASDR) = 0.91; age-standardised DALY rate 15.33 per 100,000). High SBP accounted for 23,131 deaths (16,746–30,145) and 385,281 DALYs (281,872–495,327) (ASDR = 2.24; DALY rate 36.17 per 100,000). Burden was highest in Eastern Europe and lowest in East Asia; men exceeded women across ages. From 1990 to 2021, AAPC declined for high BMI (deaths –1.10; DALYs –1.13) and more steeply for high SBP (deaths –1.67; DALYs –1.70). Socioeconomic inequality narrowed over time. Projections to 2050 indicate rising absolute counts due to population ageing, despite stable or declining rates.
Conclusions:
These findings support strengthened hypertension control and sustained obesity prevention, particularly in older men and high-burden regions, alongside improved access to screening and vascular care.
REFERENCES (39)
1.
Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2022; 146: e334-482.
2.
Howard DPJ, Banerjee A, Fairhead JF, et al. Population-based incidence of acute abdominal aortic aneurysm and the impact of screening strategy. J Am Heart Assoc 2015; 4: e001926.
3.
Song P, Rudan I, Zhu Y, et al. Global and regional prevalence of abdominal aortic aneurysms: a systematic review and modelling analysis. Ann Surg 2023; 277: 912-9.
4.
Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res 2018; 123: 825-48.
5.
Wu Y, Xiang S, Xie Y, et al. Body mass index and the risk of abdominal aortic aneurysm: a meta-analysis and dose-response analysis. Int J Surg 2024; 109: 2512-23.
6.
Kobeissi E, Hibino M, Pan H, Aune D. Blood pressure, hypertension and the risk of abdominal aortic aneurysms: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2019; 34: 547-55.
7.
Golledge J, Thanigaimani S, Powell JT, Tsao PS. Pathogenesis and management of abdominal aortic aneurysm. Eur Heart J 2023; 44: 2682-97.
8.
Wei L, Bu X, Wang X, et al. Global burden of aortic aneurysm and attributable risk factors, 1990-2017. Glob Heart 2021; 16: 35.
9.
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2162-203.
10.
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2100-32.
11.
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability, disability-adjusted life-years, and healthy life expectancy for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2133-61.
12.
GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 1989-2056.
13.
Das Gupta P. Standardization and Decomposition of Rates: A User’s Manual. Washington, DC: US Bureau of the Census; 1993.
14.
Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biomed J 2017; 59: 531-49.
15.
Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670-82.
16.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3,663 studies with 222 million participants. Lancet 2024; 403: 1027-50.
17.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. Lancet 2021; 398: 957-80.
18.
Avesta L, Rasoolzadeh S, Naeim M, Kamran A. Prevalence of cardiovascular disease risk factors in the women population covered by health centers in Ardabil. Int J Hypertens 2022; 2022: 2843249.
19.
US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, et al. Screening for abdominal aortic aneurysm: US Preventive Services Task Force recommendation statement. JAMA 2019; 322: 2211-8.
20.
Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of abdominal aortic aneurysm: a systematic review and meta-analysis of prospective studies. Sci Rep 2018; 8: 14786.
21.
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2021; 397: 2337-60.
22.
Oliver-Williams C, Sweeting MJ, Turton G, et al. Safety of men with small and medium abdominal aortic aneurysm under surveillance in the NHS AAA Screening Programme. Circulation 2019; 139: 1371-80.
23.
Wanhainen A, Hultgren R, Linné A, et al. Outcome of the Swedish nationwide abdominal aortic aneurysm screening program. Circulation 2016; 134: 1141-8.
24.
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risks, 1990-2022: update from the GBD study. J Am Coll Cardiol 2023; 82: 2350-473.
25.
Meara JG, Leather AJM, Hagander L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 2015; 386: 569-624.
26.
Pouncey AL, David M, Morris RI, et al. Systematic review and meta-analysis of sex-specific differences in adverse events after open and endovascular intact abdominal aortic aneurysm repair: consistently worse outcomes for women. Eur J Vasc Endovasc Surg 2021; 62: 367-78.
27.
Lo RC, Bensley RP, Hamdan AD, Wyers M, Adams JE, Schermerhorn ML. Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. J Vasc Surg 2013; 57: 1261-8.e1-5.
28.
Duncan A, Venn S, Forrest A, et al. Ultrasound screening for abdominal aortic aneurysm in high-risk women (FAST): outcomes of a targeted screening programme. Ann R Coll Surg Engl 2021; 103: 571-9.
29.
Phillips AR, Andraska EA, Reitz KM, et al. Any postoperative surveillance improves survival after endovascular repair of ruptured abdominal aortic aneurysms. Ann Vasc Surg 2021; 80: 50-9.
30.
Li C, Mohammed I, Arthur-Atta N, et al. The impact of completion and follow-up endoleaks on survival and reintervention after EVAR. J Vasc Surg 2023; 78: 170-80.
31.
Goodney PP, Columbo JA, Kang R, et al. Use of linked registry-claims data for long-term surveillance after EVAR (VQI-VISION). BMJ 2022; 378: e069043.
32.
Fleming KA, Horton S, Wilson ML, et al. The Lancet Commission on diagnostics: transforming access to diagnostics. Lancet 2021; 398: 1997-2050.
33.
Kempthorne P, Morriss WW, Mellin-Olsen J, Gore-Booth J. The WFSA Global Anesthesia Workforce Survey. Anesth Analg 2017; 125: 981-90.
34.
Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health 2018; 6: e1196-252.
35.
GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2204-56.
36.
Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet 2019; 394: 1231-42.
37.
Joseph P, Roshandel G, Gao P, et al. Fixed-dose combination therapies with and without aspirin in primary prevention of cardiovascular disease: a meta-analysis of randomised controlled trials. Lancet 2021; 398: 1133-46.
38.
Swinburn BA, Kraak VI, Allender S, et al. the global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. Lancet 2019; 393: 791-846.
39.
Png CYM, Yoong SY, Goh HM, et al. Decrease in mortality from abdominal aortic aneurysms is associated with reduction in smoking prevalence. Eur J Vasc Endovasc Surg 2021; 61: 947-55.